Codetta Bio introduced the Concerto platform at AACR in 2025 and initially made the technology available through a service-based Technology Access Program (TAP). Following strong customer engagement ...
NeoGenomics announced the launch of RaDaR® ST, its circulating tumor DNA assay for detecting molecular residual disease.
Plasma samples, clinical data, and imaging results were collected from 319 patients. A tumor-informed ctDNA assay was used for analysis. Patients were divided into discovery (167 patients) and ...
Multiomic Characterization of RCC1 and RCC2 Expression and Their Association With Molecular Alterations, Immune Phenotypes, and Cancer Outcomes This retrospective analysis included patients with ...
Researchers at the Icahn School of Medicine at Mount Sinai have reported promising findings that may help redefine treatment for patients with muscle-invasive bladder cancer, a potentially aggressive ...
The epigenetic modification, DNA methylation, is characterized by 5-methylcytosine (5-mC) and found in specific genomic locations, most notably regulatory regions such as promoters and enhancers.
DNA is the blueprint of life. Genes encode proteins and serve as the body's basic components. However, building a functioning ...
n the mid-1980s, tragedy struck two villages in Leicestershire, England. In two separate instances, three years apart, two teenage girls were raped and murdered on their way home from school. On ...
Creating a clear and well-defined bioanalytical methodology to quantify humoral and cellular immune responses is critical for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results